http://medblaster.com/index.php Fri, 09 May 2008 23:02:26 +0000 http://backend.userland.com/rss092 en Job Seekers: Blast Your Resume Now! Blast your resume to dozens of medical sales recruiters! Pro-actively advance your career search by blasting your resume directly to dozens of pharmaceutical, medical, and biotech sales recruiters' and employers' INBOX. Members include Merck, Ventiv, Warner Labs, and more! Once your resume is sent you ... http://medblaster.com/index.php/2008/04/03/medblaster-beta-20-2/ St. Jude Medical, Inc. (NYSE:STJ) today announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented today at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after ... http://medblaster.com/index.php/2008/05/09/results-of-brodmann-area-25-deep-brain-stimulation-pilot-study-offer-hope-for-patients-with-severe-depression/ Sanofi-Aventis SA and Bristol-Myers Squibb Co. are facing possible generic competition in Europe to the world's second biggest-selling drug, Plavix, less than a year after they beat back generic competition in the U.S. Blast Your Resume to over 100 Pharmaceutical Recruiters and Employers READ FULL STORY AT THE WALL STREET JOURNAL http://medblaster.com/index.php/2008/05/09/sanofi-bristol-myers-may-face-generic-competition-to-plavix/ Ranbaxy Laboratories and Merck have decided to sign a broadbased collaborative research agreement, reports CNBC-TV18, quoting sources. The agreement is for a new drug discovery. Blast Your Resume to over 100 Pharmaceutical Recruiters and Employers READ FULL STORY http://medblaster.com/index.php/2008/05/09/ranbaxy-merck-to-sign-deal-on-drug-discovery/ NEW YORK - Drug makers, including Pfizer Inc. and Merck & Co., have deceptively marketed their products to the public, showing the need to limit drug advertisements, lawmakers and the American Medical Association said. Blast Your Resume to over 100 Pharmaceutical Recruiters and Employers READ MORE....... http://medblaster.com/index.php/2008/05/09/ama-calls-for-limits-on-drug-ads/ About 350 jobs will be pared from the company’s local workforce, which currently numbers approximately 8,000. The company’s headquarters, as well as its cardiac rhythm disease management and neurological businesses are based here. Blast Your Resume to over 100 Pharmaceutical Recruiters and Employers READ FULL STORY HERE http://medblaster.com/index.php/2008/05/06/medtronic-to-cut-1100-jobs/ The Cambridge office of Swiss drug maker Novartis AG has released encouraging preliminary results for an experimental meningitis vaccine - a vaccine that could be used to treat infants as well as children. Blast Your Resume to over 100 Pharmaceutical Recruiters and Employers In a clinical test, Novartis, which has about 2,000 ... http://medblaster.com/index.php/2008/05/06/novartis-has-high-hopes-for-vaccine-candidate/ Merck & Co., the third-largest U.S. drugmaker, said it will eliminate 1,200 U.S. sales jobs, accelerating cost cutting after regulators last week rejected its bid to sell the cholesterol pill Cordaptive. Sales people will be notified by the end of this month and will leave by the end of July, the ... http://medblaster.com/index.php/2008/05/06/merck-cutting-us-sales-force-by-1200-to-trim-costs/ MOUNTAIN VIEW, CA and TOKYO--(Marketwire - May 6, 2008) - REGiMMUNE Corporation, a privately held biopharmaceutical company, announced today that it has closed its Series B financing for a total of $8 million U.S. Proceeds from the financing will be used to advance the company's lead program, RGI-2001, to human ... http://medblaster.com/index.php/2008/05/06/regimmune-raises-8000000-in-series-b-financing/ Acquisition of dermal filler product enhances company's aesthetic portfolio CORAL GABLES, Fla., May 6 /PRNewswire/ -- Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, announced today that it has acquired ABR Invent and ABR Development, developers of the dermal filler Atlean(R). Stiefel will acquire all shares of ... http://medblaster.com/index.php/2008/05/06/stiefel-laboratories-inc-acquires-abr-invent-and-abr-development/